Dubai – Mubasher: South Africa’s healthcare provider Mediclinic Middle East on Sunday announced the acquisition of a minority stake in Bourn Hall International MENA Limited, the holding company for the Bourn Hall Fertility Centre in the UAE, for an undisclosed amount.
Mediclinic Middle East is part of Mediclinic International, which is a private hospital group with three operating platforms in the UAE, Southern Africa, and Switzerland, in addition to holding a 29.9% stake in the UK’s Spire Healthcare.
The takeover sets the ground for a partnership focused on a long-term MENA-centred expansion in the field of Assisted Reproduction, the healthcare provider said.
“In a first step, Bourn Hall Fertility Centre will take over operations of Mediclinic Middle East’s existing IVF clinic located at Mediclinic Al Ain Hospital, and operate it under the Bourn Hall umbrella, as Bourn Hall International MENA Ltd. will continue to operate and manage its IVF business independently and under its existing brand,” the statement added.
Bourn Hall Fertility Centre in Dubai has become the only fertility center in the Middle East to be accredited by JCI, the US oldest and largest standards-setting and accrediting body in healthcare.
Commenting on the partnership, CEO of Bourn Hall International Hoda Abou-Jamra said that “we are very pleased to have found such a reputable strategic partner to further grow Bourn Hall International MENA Ltd. within the UAE and the MENA region which present significant opportunities for the growth of IVF clinics.”
He added that the increase of infertility levels is not met by a sufficient supply of high-quality, state-of-the-art IVF providers.
For his part, Mediclinic Middle East’s CEO David Hadley said that “we are delighted to be working with Bourn Hall International MENA Limited, a brand synonymous with IVF, to expand Mediclinic Middle East’s presence in this growing and important market. Their reputation for trusted expertise and quality outcomes matches our own.”
